Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Beacon BNX™ Endoscopic Ultrasound (EUS)-Needle vs SharkCore™ Needle

NCT: NCT02872831 · WITHDRAWN

NCT IDNCT02872831
StatusWITHDRAWN
Start Date2016-07
Completion2017-11

Brief Summary

The primary objective of this proposed prospective randomized, multi-center study is to evaluate the capability of the new 22G SharkCore™ needle to obtain tissue specimens and to compare its performance against the standard 22G BNX Endoscopic Ultrasound Fine needle aspiration (Beacon Endoscopic, Newton, MA) needle in the evaluation of solid mass lesions in the pancreas and gastrointestinal tract. The secondary objective is to determine the ability of the 22G SharkCore™ needle system to yield histologic tissue.

Frequently Asked Questions

What is Beacon BNX™ Endoscopic Ultrasound (EUS)-Needle vs SharkCore™ Needle?

Beacon BNX™ Endoscopic Ultrasound (EUS)-Needle vs SharkCore™ Needle is a clinical trial registered under NCT02872831. Current status: WITHDRAWN.

What is the status of NCT02872831?

The current status of NCT02872831 (Beacon BNX™ Endoscopic Ultrasound (EUS)-Needle vs SharkCore™ Needle) is: WITHDRAWN.

When did Beacon BNX™ Endoscopic Ultrasound (EUS)-Needle vs SharkCore™ Needle start?

Beacon BNX™ Endoscopic Ultrasound (EUS)-Needle vs SharkCore™ Needle started on 2016-07.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑